Laura Yecies is an accomplished leader in medical technology, dedicated to transforming healthcare through innovation. As CEO of Osteoboost Health, Inc., she is tackling the global low bone density epidemic with the Osteoboost precision vibration therapy device, the first medical device approved by the FDA to treat osteopenia. A seasoned executive with a track record of scaling disruptive technologies, Ms. Yecies has led multiple high-growth companies, including NeuroSync, Catch (acquired by Apple), and SugarSync (acquired by J2Global). Earlier in her career, she played a pivotal role in shaping the digital landscape, leading the Browser division at Netscape, Yahoo’s Mail, and global marketing at cybersecurity giant Check Point. She holds an MBA from Harvard, an MSFS from Georgetown, and an AB in Government, magna cum laude, from Dartmouth. A sought-after speaker, podcaster, and writer on healthcare and technology, Ms. Yecies has been profiled in The New York Times, Forbes, and numerous industry publications.